Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane

Akshay Sabnis1, Katheryn Lh Hagart1, Anna Klöckner1,2,3,4

  • 1MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.

Elife
|April 6, 2021
PubMed

Insights

Colistin resistance is rising. New research shows colistin kills bacteria by targeting lipopolysaccharide (LPS) in the cytoplasmic membrane, not the outer membrane. This discovery enables new therapeutic strategies against resistant bacteria.

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Colistin is a critical last-resort antibiotic with limitations in efficacy and increasing resistance.
  • The precise bactericidal mechanism of colistin, particularly its interaction with bacterial membranes, remained incompletely understood.
  • Lipopolysaccharide (LPS) modification, mediated by MCR-1, was identified as a key factor in colistin resistance.

Purpose of the Study:

  • To elucidate the exact mechanism by which colistin exerts its bactericidal activity.
  • To investigate the role of LPS localization in colistin resistance and susceptibility.
  • To develop novel therapeutic strategies for combating colistin-resistant bacterial infections.

Main Methods:

  • Investigated MCR-1 mediated colistin resistance in *Escherichia coli*, focusing on LPS modification.
  • Determined colistin's bactericidal action by analyzing its interaction with LPS in different cellular compartments (cytoplasmic membrane vs. outer membrane).
  • Utilized the LPS transport inhibitor murepavadin to induce LPS accumulation in *Pseudomonas aeruginosa*'s cytoplasmic membrane, followed by colistin treatment.

Main Results:

  • Discovered that MCR-1 mediated colistin resistance in *Escherichia coli* is linked to LPS modification in the cytoplasmic membrane, not the outer membrane.
  • Demonstrated that colistin's bactericidal effect stems from targeting LPS within the cytoplasmic membrane.
  • Showed that inhibiting LPS transport with murepavadin enhances *Pseudomonas aeruginosa*'s susceptibility to colistin in vitro and improves treatment efficacy in vivo.

Conclusions:

  • Colistin's primary bactericidal mechanism involves targeting lipopolysaccharide (LPS) in the cytoplasmic membrane.
  • LPS modification in the cytoplasmic membrane is crucial for MCR-1 mediated colistin resistance.
  • Combining LPS transport inhibition with colistin presents a promising therapeutic strategy to overcome colistin resistance and improve treatment outcomes.

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
541
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.1K
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
226
Bacterial Phylum Planctomycetes01:26

Bacterial Phylum Planctomycetes

Planctomycetes are a group of morphologically distinct bacteria predominantly classified into two orders: Planctomycetales and Brocadiales. These gram-negative bacteria exhibit unique features, including division by budding and the presence of stalks or appendages. Their cells are often found in rosette arrangements, and they are notable for possessing an S-layer in their cell envelope, which is relatively uncommon among bacteria. Additionally, Planctomycetes frequently exhibit intracellular...
206
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K